We are live on ! Find out more
MREO

Mereo BioPharma
MREO

14 hedge funds and large institutions have $4.08M invested in Mereo BioPharma in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.59% less ownership

Funds ownership: 1.86% → 1.27% (-0.59%)

13% less funds holding

Funds holding: 16 → 14 (-2)

22% less capital invested

Capital invested by funds: $5.21M → $4.08M (-$1.13M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
1
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$14.9K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$1.52M
2
BC
Birchview Capital
Vermont
-$231K
3
Primecap Management
Primecap Management
California
-$208K
4
Renaissance Technologies
Renaissance Technologies
New York
-$102K
5
CL
CSS LLC
Illinois
-$66.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Primecap Management
1
Primecap Management
California
$1.97M -$208K -81,594 -12%
DMPV
2
Delphi Management Partners VIII
California
$842K +$656K +256,734 New
PA
3
Perceptive Advisors
New York
$588K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$414K -$102K -39,800 -24%
CL
5
CSS LLC
Illinois
$171K -$66.5K -26,008 -33%
State Street
6
State Street
Massachusetts
$54K – – –
UBS Group
7
UBS Group
Switzerland
$23K +$14.9K +5,845 +520%
Morgan Stanley
8
Morgan Stanley
New York
$8K -$61.8K -24,196 -92%
Bank of America
9
Bank of America
North Carolina
$6K -$26.7K -10,449 -86%
Rockefeller Capital Management
10
Rockefeller Capital Management
New York
$1K – – –
Wells Fargo
11
Wells Fargo
California
$1K – – –
BI
12
BVF Inc
California
– -$1.52M -523,382 Closed
BC
13
Birchview Capital
Vermont
– -$231K -77,570 Closed
BCM
14
Bridgeway Capital Management
Texas
– -$46K -15,961 Closed
TRCT
15
Tower Research Capital (TRC)
New York
– -$5K -1,738 Closed
TI
16
tru Independence
Oregon
– +$161 +63 New

MREO Hedge Fund Activity: Q4 2019 in Review

14 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Mereo BioPharma (MREO) for Q4 2019, worth a combined $4.08M — down 22% from $5.21M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of MREO and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $14.9K. The largest seller was BVF Inc, exiting entirely with an estimated $1.52M sold.

  • 14 institutional investors held Mereo BioPharma (MREO) as of Q4 2019, down from 16 in Q3 2019.
  • Funds reported $4.08M of Mereo BioPharma stock for Q4 2019, down 22% quarter-over-quarter.
  • 2 funds opened new Mereo BioPharma positions in Q4 2019 and 4 closed out, a net change of -2 holders.
  • The largest Mereo BioPharma buyer in Q4 2019 was UBS Group, an estimated $14.9K added.
  • The largest Mereo BioPharma seller in Q4 2019 was BVF Inc, an estimated $1.52M sold.

Based on aggregated 13F filings for Q4 2019.